Product development

Osteo-Pharma is a life sciences company focused on the development of novel pharmaceuticals and medical devices to promote the local healing of bone fractures or defects.


Our research will focus on improving bone regeneration near the site of a fracture by simultaneously stimulating bone formation and inhibiting bone resorption. The latter will be achieved by encapsulating 2 bone enhancing compounds into a biodegradable carrier that allows sustained release of the 2 compounds over a 5-7 week period.

Area of work

Regenerative medicine, Drug development, Controlled release systems, Orthopedics, Dental

``At Pivot Park we can make use of an excellent infrastructure and network, fully equipped laboratories and very expensive equipment that we would otherwise have had to purchase ourselves. As a result, we do not have to make any major investments in equipment at this time and we can focus on our research.``

News from Osteo-Pharma

Osteo-Pharma receives MREC approval for initiation of clinical trial

10 May 21

Osteo-Pharma Release: Successful Preclinical Dental defect study Demonstrates Enhanced Bone Regeneration Properties of OsteoActivator coated collagen membranes

24 Jul 19

Regenerative medicine crossing borders

06 Mar 17